Novo Nordisk growth lifts Denmark’s 2026 forecast to 4%
AI Summary- Danmarks Nationalbank raised Denmark’s growth forecast after stronger pharmaceutical expansion.
- Denmark’s 2026 growth forecast increased to 4% from the earlier 1.8% estimate.
- Novo Nordisk’s overseas production limits the domestic economic benefit, the central bank said.